{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:55:29Z","timestamp":1793854529234,"version":"4.6.1"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T00:00:00Z","timestamp":1719360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["GR2019-1237019"],"award-info":[{"award-number":["GR2019-1237019"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.pcad.2024.06.003","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T23:08:21Z","timestamp":1719356901000},"page":"2-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Stratified medicine for acute and chronic coronary syndromes: A patient-tailored approach"],"prefix":"10.1016","volume":"85","author":[{"given":"Rocco A.","family":"Montone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Galli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Bland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominick J.","family":"Angiolillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Kaski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Crea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcad.2024.06.003_bb0005","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1056\/NEJMp2033115","article-title":"Conquering atherosclerotic cardiovascular disease \u2014 50 years of Progress","volume":"384","author":"Gibbons","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2024.06.003_bb0010","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2024.06.003_bb0015","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1056\/NEJMsb1503104","article-title":"Precision medicine\u2014personalized, problematic, and promising","volume":"372","author":"Jameson","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2024.06.003_bb0020","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1016\/j.jacc.2021.04.001","article-title":"Precision medicine approaches to vascular disease: JACC focus seminar 2\/5","volume":"77","author":"Miller","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2024.06.003_bb0025","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1161\/CIRCRESAHA.117.310782","article-title":"Emerging role of precision medicine in cardiovascular disease","volume":"122","author":"Leopold","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.pcad.2024.06.003_bb0030","first-page":"1","article-title":"Building a knowledge network for biomedical research and a new taxonomy of disease","author":"Toward Precision Medicine","year":"2011","journal-title":"Towar Precis Med Build a Knowl Netw Biomed Res a New Taxon Dis"},{"key":"10.1016\/j.pcad.2024.06.003_bb0035","unstructured":"Realising the potential of stratified medicine | The Academy of Medical Sciences https:\/\/acmedsci.ac.uk\/more\/news\/realising-the-potential-of-stratified-medicine (30 May 2023)."},{"key":"10.1016\/j.pcad.2024.06.003_bb0040","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"ESC guidelines for the management of acute coronary syndromes","volume":"38","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2024.06.003_bb0045","first-page":"E4","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: executive summary: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"145","author":"Lawton","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2024.06.003_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2020.551796","article-title":"Feasibility of CardioSecur\u00ae, a Mobile 4-electrode\/22-Lead ECG device, in the prehospital emergency setting","volume":"7","author":"Spaich","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.pcad.2024.06.003_bb0055","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/eurheartj\/ehs411","article-title":"Update on acute coronary syndromes: the pathologists\u2019 view","volume":"34","author":"Falk","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2024.06.003_bb0060","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1161\/CIRCRESAHA.118.311098","article-title":"Reassessing the mechanisms of acute coronary syndromes","volume":"124","author":"Libby","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.pcad.2024.06.003_bb0065","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.jacc.2013.05.071","article-title":"In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography","volume":"62","author":"Jia","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2024.06.003_bb0070","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1093\/eurheartj\/ehz332","volume":"40","author":"Johnson","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2024.06.003_bb0075","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/s41569-022-00687-9","article-title":"Optical coherence tomography in coronary atherosclerosis assessment and intervention","volume":"19","author":"Araki","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.pcad.2024.06.003_bb0080","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1093\/eurheartj\/ehad334","article-title":"Culprit plaque morphology determines inflammatory risk and clinical outcomes in acute coronary syndrome","volume":"44","author":"Gerhardt","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2024.06.003_bb0085","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jacc.2007.04.086","article-title":"Frequency and distribution of thin-cap fibroatheroma and ruptured plaques in human coronary arteries: a pathologic study","volume":"50","author":"Cheruvu","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2024.06.003_bb0090","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1161\/ATVBAHA.108.179739","article-title":"Concept of vulnerable\/unstable plaque","volume":"30","author":"Finn","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pcad.2024.06.003_bb0095","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1016\/j.jacc.2011.08.055","article-title":"High-sensitivity C-reactive protein is within normal levels at the very onset of first ST-segment elevation acute myocardial infarction in 41% of cases: a multiethnic case-control study","volume":"58","author":"Cristell","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2024.06.003_bb0100","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/ehjci\/jew208","article-title":"Not all plaque ruptures are born equal: an optical coherence tomography study","volume":"18","author":"Scalone","year":"2017","journal-title":"Eur Hear J Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2024.06.003_bb0105","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1161\/CIRCULATIONAHA.117.029870","article-title":"Acute coronary syndromes: the way forward from mechanisms to precision treatment","volume":"136","author":"Crea","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2024.06.003_bb0110","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1093\/eurheartj\/ehv653","article-title":"Cholesterol crystal induced arterial inflammation and destabilization of atherosclerotic plaque","volume":"37","author":"Janoudi","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2024.06.003_bb0115","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1093\/eurheartj\/ehw024","article-title":"Residual inflammatory risk: addressing the obverse side of the atherosclerosis prevention coin","volume":"37","author":"Ridker","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2024.06.003_bb0120","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.amjcard.2011.02.336","article-title":"Effect of statins on cholesterol crystallization and atherosclerotic plaque stabilization","volume":"107","author":"Abela","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2024.06.003_bb0125","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1161\/ATVBAHA.111.226167","article-title":"Plaque rupture and thrombosis are reduced by lowering cholesterol levels and crystallization with ezetimibe and are correlated with fluorodeoxyglucose positron emission tomography","volume":"31","author":"Patel","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pcad.2024.06.003_bb0130","first-page":"8","article-title":"Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming","author":"Zimmer","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.pcad.2024.06.003_bb0135","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/eurheartj\/ehv029","article-title":"Plaque rupture and intact fibrous cap assessed by optical coherence tomography portend different outcomes in patients with acute coronary syndrome","volume":"36","author":"Niccoli","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2024.06.003_bb0140","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.jcin.2015.02.026","volume":"8","author":"Higuma","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2024.06.003_bb0145","first-page":"6","article-title":"Management and outcome of patients with acute coronary syndrome caused by plaque rupture versus plaque Erosion: an intravascular optical coherence tomography study","author":"Hu","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.pcad.2024.06.003_bb0150","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1056\/NEJMoa067731","article-title":"Stent thrombosis in randomized clinical trials of drug-eluting stents","volume":"356","author":"Mauri","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2024.06.003_bb0155","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(07)61444-5","article-title":"Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis","volume":"370","author":"Stettler","year":"2007","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.pcad.2024.06.003_bb0160","first-page":"792","article-title":"Effective anti-thrombotic therapy without stenting: intravascular optical coherence tomography-based management in plaque erosion (the EROSION study)","volume":"38","author":"Jia","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2024.06.003_bb0165","first-page":"10","article-title":"EROSION study (effective anti-thrombotic therapy without stenting: intravascular optical coherence tomography-based Management in Plaque Erosion): a 1-year follow-up report","author":"Xing","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2024.06.003_bb0170","doi-asserted-by":"crossref","first-page":"497","DOI":"10.4244\/EIJ-D-20-00299","article-title":"Predictors of non-stenting strategy for acute coronary syndrome caused by plaque erosion: four-year outcomes of the EROSION study","volume":"17","author":"He","year":"2021","journal-title":"EuroIntervention"},{"key":"10.1016\/j.pcad.2024.06.003_bb0175","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.jcin.2022.01.298","article-title":"EROSION III: a multicenter RCT of OCT-guided reperfusion in STEMI with early infarct artery patency","volume":"15","author":"Jia","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2024.06.003_bb0180","doi-asserted-by":"crossref","first-page":"482","DOI":"10.4244\/EIJ-D-21-00950","article-title":"Clinical outcomes of no stenting in patients with ST-segment elevation myocardial infarction undergoing deferred primary percutaneous coronary intervention","volume":"18","author":"Madsen","year":"2022","journal-title":"EuroIntervention"},{"key":"10.1016\/j.pcad.2024.06.003_bb0185","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1161\/01.ATV.20.5.1262","article-title":"Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions","volume":"20","author":"Virmani","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pcad.2024.06.003_bb0190","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1253\/circj.CJ-14-0108","article-title":"Impact of target lesion coronary calcification on stent expansion","volume":"78","author":"Kobayashi","year":"2014","journal-title":"Circ J"},{"key":"10.1016\/j.pcad.2024.06.003_bb0195","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.jcin.2020.03.053","article-title":"Coronary calcification and long-term outcomes according to drug-eluting stent generation","volume":"13","author":"Guedeney","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2024.06.003_bb0200","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000481931","article-title":"Features and outcomes of patients with calcified nodules at culprit lesions of acute coronary syndrome: an optical coherence tomography study","volume":"139","author":"Kobayashi","year":"2018","journal-title":"Cardiology"},{"key":"10.1016\/j.pcad.2024.06.003_bb0205","doi-asserted-by":"crossref","first-page":"e2182","DOI":"10.4244\/EIJ-D-17-00962","article-title":"A new optical coherence tomography-based calcium scoring system to predict stent underexpansion","volume":"13","author":"Fujino","year":"2018","journal-title":"EuroIntervention"},{"key":"10.1016\/j.pcad.2024.06.003_bb0210","doi-asserted-by":"crossref","first-page":"e618","DOI":"10.1161\/CIR.0000000000000617","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"138","author":"Thygesen","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2024.06.003_bb0215","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ijcard.2013.12.238","article-title":"Morphological-biohumoral correlations in acute coronary syndromes: pathogenetic implications","volume":"171","author":"Niccoli","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pcad.2024.06.003_bb0220","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1161\/CIRCULATIONAHA.110.955302","article-title":"High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study","volume":"122","author":"Ferrante","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2024.06.003_bb0225","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.jacc.2018.06.072","article-title":"Alterations of Hyaluronan metabolism in acute coronary syndrome: implications for plaque Erosion","volume":"72","author":"Pedicino","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2024.06.003_bb0230","doi-asserted-by":"crossref","first-page":"E1371","DOI":"10.4244\/EIJ-D-21-00904","article-title":"Antiplatelet therapy after percutaneous coronary intervention","volume":"17","author":"Angiolillo","year":"2022","journal-title":"EuroIntervention"},{"key":"10.1016\/j.pcad.2024.06.003_bb0235","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/eurheartj\/ehv104","article-title":"Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention","volume":"36","author":"Aradi","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2024.06.003_bb0240","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/S0140-6736(21)00533-X","article-title":"Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis","volume":"397","author":"Galli","year":"2021","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.pcad.2024.06.003_bb0245","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jcin.2021.01.024","article-title":"Effect of CYP2C19 genotype on ischemic outcomes during Oral P2Y12 inhibitor therapy: a Meta-analysis","volume":"14","author":"Pereira","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2024.06.003_bb0250","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.jcin.2019.03.034","article-title":"Updated expert consensus statement on platelet function and genetic testing for guiding P2Y12 receptor inhibitor treatment in percutaneous coronary intervention","volume":"12","author":"Sibbing","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2024.06.003_bb0255","doi-asserted-by":"crossref","first-page":"E011990","DOI":"10.1161\/CIRCINTERVENTIONS.122.011990","article-title":"Comparison of unguided de-escalation versus guided selection of dual antiplatelet therapy after acute coronary syndrome: a systematic review and network meta-analysis","volume":"15","author":"Kuno","year":"2022","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2024.06.003_bb0260","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ijcard.2021.10.010","article-title":"Guided selection of antiplatelet therapy in acute coronary syndrome: impact on outcomes and resource utilization","volume":"345","author":"Galli","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pcad.2024.06.003_bb0265","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0140-6736(16)31323-X","article-title":"Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised controlled superiority trial","volume":"388","author":"Cayla","year":"2016","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.pcad.2024.06.003_bb0270","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0140-6736(17)32155-4","article-title":"Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial","volume":"390","author":"Sibbing","year":"2017","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.pcad.2024.06.003_bb0275","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJMoa1907096","article-title":"A genotype-guided strategy for Oral P2Y12 inhibitors in primary PCI","volume":"381","author":"Claassens","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2024.06.003_bb0280","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.jacc.2018.02.029","article-title":"Pharmacogenomic approach to selecting antiplatelet therapy in patients with acute coronary syndromes: the PHARMCLO trial","volume":"71","author":"Notarangelo","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2024.06.003_bb0285","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijcard.2021.08.051","article-title":"Bedside testing of CYP2C19 vs. conventional clopidogrel treatment to guide antiplatelet therapy in ST-segment elevation myocardial infarction patients","volume":"343","author":"Al-Rubaish","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pcad.2024.06.003_bb0290","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/jama.2020.12443","article-title":"Effect of genotype-guided Oral P2Y12 inhibitor selection vs conventional Clopidogrel therapy on ischemic outcomes after percutaneous coronary intervention: the TAILOR-PCI randomized clinical trial","volume":"324","author":"Pereira","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2024.06.003_bb0295","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/eurheartj\/ehab836","article-title":"Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials","volume":"43","author":"Galli","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2024.06.003_bb0300","doi-asserted-by":"crossref","first-page":"E891","DOI":"10.1161\/CIR.0000000000000670","article-title":"Contemporary diagnosis and Management of Patients with Myocardial Infarction in the absence of obstructive coronary artery disease: a scientific statement from the American Heart Association","volume":"139","author":"Tamis-Holland","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2024.06.003_bb0305","first-page":"10","article-title":"Interplay between myocardial bridging and coronary spasm in patients with myocardial ischemia and non-obstructive coronary arteries: pathogenic and prognostic implications","author":"Montone","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.pcad.2024.06.003_bb0310","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1253\/circj.CJ-21-0848","article-title":"Pathophysiology of coronary microvascular dysfunction","volume":"86","author":"Crea","year":"2022","journal-title":"Circ J"},{"key":"10.1016\/j.pcad.2024.06.003_bb0315","doi-asserted-by":"crossref","first-page":"E666","DOI":"10.4244\/EIJ-D-21-00971","article-title":"Safety and prognostic relevance of acetylcholine testing in patients with stable myocardial ischaemia or myocardial infarction and non-obstructive coronary arteries","volume":"18","author":"Montone","year":"2022","journal-title":"EuroIntervention"},{"key":"10.1016\/j.pcad.2024.06.003_bb0320","first-page":"91","article-title":"Patients with acute myocardial infarction and non-obstructive coronary arteries: safety and prognostic relevance of invasive coronary provocative tests","volume":"39","author":"Montone","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2024.06.003_bb0325","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00392-019-01523-w","article-title":"Clinical, angiographic and echocardiographic correlates of epicardial and microvascular spasm in patients with myocardial ischaemia and non-obstructive coronary arteries","volume":"109","author":"Montone","year":"2020","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.pcad.2024.06.003_bb0330","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.pcad.2021.08.004","article-title":"The evolving role of cardiac imaging in patients with myocardial infarction and non-obstructive coronary arteries","volume":"68","author":"Montone","year":"2021","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2024.06.003_bb0335","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1161\/CIRCULATIONAHA.105.606509","article-title":"Presentation, patterns of myocardial damage, and clinical course of viral myocarditis","volume":"114","author":"Mahrholdt","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2024.06.003_bb0340","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1161\/CIRCULATIONAHA.116.026336","article-title":"Medical therapy for secondary prevention and long-term outcome in patients with myocardial infarction with nonobstructive coronary artery disease","volume":"135","author":"Lindahl","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2024.06.003_bb0345","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jcin.2021.10.003","article-title":"Acetylcholine rechallenge: a first step toward tailored treatment in patients with coronary artery spasm","volume":"15","author":"Seitz","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2024.06.003_bb0350","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1093\/eurheartj\/ehy080","article-title":"European Society of Cardiology, acute cardiovascular care association, SCAD study group: a position paper on spontaneous coronary artery dissection","volume":"39","author":"Adlam","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2024.06.003_bb0355","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jacc.2017.06.053","article-title":"Spontaneous coronary artery dissection: clinical outcomes and risk of recurrence","volume":"70","author":"Saw","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2024.06.003_bb0360","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1093\/eurheartj\/ehab372","article-title":"Antiplatelet therapy in patients with conservatively managed spontaneous coronary artery dissection from the multicentre DISCO registry","volume":"42","author":"Cerrato","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2024.06.003_bb0365","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jcin.2017.08.057","article-title":"Coronary Embolus: an underappreciated cause of acute coronary syndromes","volume":"11","author":"Raphael","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2024.06.003_bb0370","doi-asserted-by":"crossref","first-page":"E933","DOI":"10.4244\/EIJ-D-22-00178","article-title":"Precision medicine versus standard of care for patients with myocardial infarction with non-obstructive coronary arteries (MINOCA): rationale and design of the multicentre, randomised PROMISE trial","volume":"18","author":"Montone","year":"2022","journal-title":"EuroIntervention"},{"key":"10.1016\/j.pcad.2024.06.003_bb0375","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/heartjnl-2018-314661","article-title":"Angina: contemporary diagnosis and management","volume":"106","author":"Ford","year":"2020","journal-title":"Heart"},{"key":"10.1016\/j.pcad.2024.06.003_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2024.117503","article-title":"Predicting the response to acetylcholine in ischemia or infarction with non-obstructive coronary arteries: the ABCD score","volume":"391","author":"Rinaldi","year":"2024","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pcad.2024.06.003_bb0385","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/eurheartj\/ehr331","article-title":"Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events","volume":"33","author":"Jespersen","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2024.06.003_bb0390","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1093\/eurheartj\/ehab282","article-title":"Clinical characteristics and prognosis of patients with microvascular angina: an international and prospective cohort study by the coronary vasomotor disorders international study (COVADIS) group","volume":"42","author":"Shimokawa","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2024.06.003_bb0395","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/eurheartj\/ehab775","article-title":"Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis","volume":"43","author":"Kelshiker","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2024.06.003_bb0400","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jcmg.2021.01.041","article-title":"Functional and economic impact of INOCA and influence of coronary microvascular dysfunction","volume":"14","author":"Schumann","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2024.06.003_bb0405","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jacc.2021.07.042","article-title":"Coronary microvascular dysfunction across the spectrum of cardiovascular diseases: JACC state-of-the-art review","volume":"78","author":"Del Buono","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2024.06.003_bb0410","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1093\/eurheartj\/ehaa503","volume":"41","author":"Kunadian","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2024.06.003_bb0415","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1016\/j.jacc.2018.09.006","article-title":"Stratified medical therapy using invasive coronary function testing in angina: the CorMicA trial","volume":"72","author":"Ford","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2024.06.003_bb0420","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jcin.2019.11.001","article-title":"1-year outcomes of angina management guided by invasive coronary function testing (CorMicA)","volume":"13","author":"Ford","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"10.1016\/j.pcad.2024.06.003_bb0425","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/CIRCULATIONAHA.123.064751","article-title":"Invasive endotyping in patients with angina and no obstructive coronary artery disease: a randomized controlled trial","volume":"149","author":"Sidik","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2024.06.003_bb0430","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1016\/j.jacc.2021.07.053","article-title":"2021 AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"78","author":"Gulati","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2024.06.003_bb0435","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/0735-1097(93)90310-W","article-title":"Randomized placebo-controlled trial of amlodipine in vasospastic angina. Amlodipine Study 160 Group","volume":"21","author":"Chahine","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2024.06.003_bb0440","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1253\/circj.CJ-10-0292","article-title":"Prognostic effects of calcium channel blockers in patients with vasospastic angina\u2014a meta-analysis","volume":"74","author":"Nishigaki","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.pcad.2024.06.003_bb0445","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0002-9149(85)90842-2","article-title":"Efficacy of calcium channel blocker therapy for angina pectoris resulting from small-vessel coronary artery disease and abnormal vasodilator reserve","volume":"56","author":"Cannon","year":"1985","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2024.06.003_bb0450","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/heartjnl-2022-321267","article-title":"Use of pharmacology in the diagnosis and management of vasomotor and microcirculation disorders","volume":"109","author":"McChord","year":"2023","journal-title":"Heart"},{"key":"10.1016\/j.pcad.2024.06.003_bb0455","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/eurheartj\/ehu313","article-title":"Prognostic impact of chronic nitrate therapy in patients with vasospastic angina: multicentre registry study of the Japanese coronary spasm association","volume":"36","author":"Takahashi","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2024.06.003_bb0460","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10557-013-6439-z","article-title":"Lack of effect of nitrates on exercise stress test results in patients with microvascular angina","volume":"27","author":"Russo","year":"2013","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.pcad.2024.06.003_bb0465","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/cvr\/cvaa006","article-title":"Treatment of coronary microvascular dysfunction","volume":"116","author":"Bairey Merz","year":"2020","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pcad.2024.06.003_bb0470","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1161\/CIRCULATIONAHA.118.031373","article-title":"Reappraisal of ischemic heart disease","volume":"138","author":"Kaski","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2024.06.003_bb0475","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0002-9149(99)00450-6","article-title":"Atenolol versus amlodipine versus isosorbide-5-mononitrate on anginal symptoms in syndrome X","volume":"84","author":"Lanza","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2024.06.003_bb0480","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jcmg.2014.12.008","article-title":"Coronary microvascular dysfunction, microvascular angina, and treatment strategies","volume":"8","author":"Marinescu","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2024.06.003_bb0485","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/01.CIR.65.2.281","article-title":"Exacerbation of vasotonic angina pectoris by propranolol","volume":"65","author":"Robertson","year":"1982","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2024.06.003_bb0490","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ahj.2011.07.011","volume":"162","author":"Pauly","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.pcad.2024.06.003_bb0495","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/HJH.0b013e328340a08e","article-title":"Perindopril and indapamide reverse coronary microvascular remodelling and improve flow in arterial hypertension","volume":"29","author":"Neglia","year":"2011","journal-title":"J Hypertens"},{"key":"10.1016\/j.pcad.2024.06.003_bb0500","first-page":"5","article-title":"Impact of statin therapy on clinical outcome in patients with coronary spasm","author":"Ishii","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.pcad.2024.06.003_bb0505","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0002-9149(97)00279-8","article-title":"Effects of short-term treatment of Nicorandil on exercise-induced myocardial ischemia and abnormal cardiac autonomic activity in microvascular angina","volume":"80","author":"Chen","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2024.06.003_bb0510","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/eurheartj\/ehv647","article-title":"A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve","volume":"37","author":"Merz","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2024.06.003_bb0515","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/hc1002.105938","article-title":"Suppression of coronary artery spasm by the rho-kinase inhibitor fasudil in patients with vasospastic angina","volume":"105","author":"Masumoto","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2024.06.003_bb0520","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0735-1097(02)02632-3","article-title":"Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm","volume":"41","author":"Mohri","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2024.06.003_bb0525","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.jacc.2019.08.1056","article-title":"Coronary functional abnormalities in patients with angina and nonobstructive coronary artery disease","volume":"74","author":"Suda","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2024.06.003_bb0530","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1093\/eurheartj\/ehz915","article-title":"Genetic dysregulation of endothelin-1 is implicated in coronary microvascular dysfunction","volume":"41","author":"Ford","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2024.06.003_bb0535","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ahj.2020.07.007","article-title":"Rationale and design of the Medical Research Council\u2019s precision medicine with Zibotentan in microvascular angina (PRIZE) trial","volume":"229","author":"Morrow","year":"2020","journal-title":"Am Heart J"},{"key":"10.1016\/j.pcad.2024.06.003_bb0540","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1016\/j.jacc.2018.07.106","article-title":"Coronary physiology beyond coronary flow Reserve in Microvascular Angina: JACC state-of-the-art review","volume":"72","author":"Gould","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2024.06.003_bb0545","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1093\/eurheartj\/ehac294","article-title":"Great debate: triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week","volume":"43","author":"De Caterina","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2024.06.003_bb0550","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1056\/NEJMoa1209979","article-title":"Bedside monitoring to adjust antiplatelet therapy for coronary stenting","volume":"367","author":"Collet","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2024.06.003_bb0555","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/ehjcvp\/pvz059","article-title":"Personalized antiplatelet therapy guided by a novel detection of platelet aggregation function in stable coronary artery disease patients undergoing percutaneous coronary intervention: a randomized controlled clinical trial","volume":"6","author":"Zheng","year":"2020","journal-title":"Eur Hear J Cardiovasc Pharmacother"},{"key":"10.1016\/j.pcad.2024.06.003_bb0560","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2024.06.003_bb0565","article-title":"Prognostic impact of hypercoagulability and impaired fibrinolysis in acute myocardial infarction","volume":"44","author":"Lee","year":"2023","journal-title":"Eur Heart J"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062024000914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062024000914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T20:13:21Z","timestamp":1724098401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062024000914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":113,"alternative-id":["S0033062024000914"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2024.06.003","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stratified medicine for acute and chronic coronary syndromes: A patient-tailored approach","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2024.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}